LIGAND PHARMACEUTICALS INCORPORATED Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, employee stock purchase plan for fiscal 2017 was -$5.56M, a 202.62% decline from fiscal 2016.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, employee stock purchase plan for fiscal 2016 was $5.42M, a 38.80% decline from fiscal 2015.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, employee stock purchase plan for fiscal 2015 was $8.85M, a 94.01% increase from fiscal 2014.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, employee stock purchase plan for fiscal 2014 was $4.56M, a 45.81% increase from fiscal 2013.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2017-12-31 | -$5.56M 10-K · filed 2018-03-01 | |
| 2016-12-31 | $5.42M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $8.85M 10-K · filed 2018-03-01 | |
| 2014-12-31 | $4.56M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $3.13M 10-K · filed 2016-11-14 | |
| 2012-12-31 | $1.10M 10-K · filed 2015-02-23 | |
| 2011-12-31 | $54.00K 10-K/A · filed 2014-12-12 | |
| 2010-12-31 | $27.00K 10-K · filed 2013-03-14 |